Skip to content

Oncologic Outcomes of Minimal Access Nipple-sparing Mastectomy Compared With Conventional Approach in Breast Cancer

Long-term Oncologic Outcomes of Minimal Access (Endoscopic or Robotic Assisted) Nipple-sparing Mastectomy Compared With Conventional Approach in Breast Cancer - a Propensity Score Matching Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07069803
Enrollment
1129
Registered
2025-07-17
Start date
2000-02-01
Completion date
2024-03-30
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

nipple-sparing mastectomy

Brief summary

In this study the investigators investigate the oncological outcomes of minimal access nipple sparing mastectomy compared with conventional nipple sparing mastectomy for the treatment of breast cancer

Detailed description

A retrospective analysis of a prospectively collected database was conducted from single institute to compare the oncologic outcomes of MA-NSM versus C-NSM. The clinical results and oncologic outcome (margin involved rate, local recurrence and overall survival) were compared between groups. To prevent bias, a case control approach was conducted with propensity score matching (PSM) method.

Interventions

None listed

Sponsors

Changhua Christian Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* primary operable breast cancer and had undergone NSM

Exclusion criteria

* had metastatic disease, non-malignant breast disease cases, bilateral breast cancer cases, recurrent breast cancer as well as male breast cancer cases and patients who did not undergo NSM

Design outcomes

Primary

MeasureTime frameDescription
local recurrence10 yearslocal recurrence
distant metastasis10 yearsdistant metastasis
disease free survival10 yearsdisease free survival
overall survival10 yearsoverall survival

Secondary

MeasureTime frameDescription
intra-operative blood lossduring surgeryintra-operative blood loss
post-operative complications30 days post-operativelypost-operative complications
operative durationduring surgeryoperative duration

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026